Bulletins - Interactions
Filter by category:
AdministrationAdverse drug reactionsCannabis-based productsComplementary and Alternative Medicines (CAMs)Drug comparisonsExtremes of Age – paediatric and elderlyInteractionsNew medicineOtherPharmacokineticPregnancy/Breastfeeding


Drug-Induced QTc Interval Prolongation - February 13, 2020
The risk of developing a life threatening arrhythmia at any given QTc interval (the QT interval corrected for heart rate) varies widely between patients. In patients with a high baseline risk of QTc prolongation, QTc prolonging drugs should be either avoided or the QTc interval should be monitore...



Oral Anticoagulants – Rivaroxaban and Dabigatran - October 1, 2019
Rivaroxaban (Factor Xa inhibitor), dabigatran etexilate (direct thrombin inhibitor), or warfarin (vitamin K epoxide reductase inhibitor) can be used as oral anticoagulants for most indications. Warfarin remains first line for patients with mechanical heart valves or severe chronic kidney disease....



Vildagliptin for diabetes – funded in NZ - March 29, 2019
There are over 240,000 people in NZ currently diagnosed with diabetes mellitus (mostly type 2), and possibly another 100,000 undiagnosed. In October 2018, vildagliptin became the first dipeptidyl peptidase-4 (DPP-4) inhibitor funded in NZ. It is one of a number of DPP-4 inhibitors used internatio...



Sacubitril + valsartan for heart failure - November 5, 2018
Sacubitril + valsartan is now available in New Zealand and fully subsidised under Special Authority criteria. Eligible patients must have NYHA/WHO functional class II, III or IV heart failure; a left ventricular ejection fraction of <35%; and be receiving standard heart failure therapy. It can...



Interactions between herbal products and conventional medicines - July 9, 2014
Herbal products are commonly used by many patients alongside conventional medicines. The aim of this bulletin is to describe potential interactions with five popular products; St John’s wort, ginkgo, garlic, echinacea and fish oil.
Pharmacokinetic interactions (see table below):
Enzym...



Drug interactions with statins - January 1, 2014
Statins are one of the most widely prescribed classes of medicines; in New Zealand over three million prescriptions were dispensed in 2012. Drug interactions may increase the risk of serious adverse reactions associated with statins, such as myopathy. Alarmingly, four Christchurch patients in a s...